FW: Google Alert - Indian patent office

 

 

From: Google Alerts [mailto:googlealerts-noreply@google.com]
Sent: 08 March 2018 07:32
To: roshan@siddhast.com
Subject: Google Alert - Indian patent office

 

Indian patent office Daily update ⋅ 8 March 2018 NEWS Torrent gets favourable order against Otsuka's patent application Business Standard Indian Patent Office has refused patent application of Japanese drug manufacturer Otsuka Pharmaceuticals for certain forms of its anti-psychotic drug aripiprazole, a medicine it sells under the brand Abilify. Torrent has been at loggerheads with Otsuka over the patent of Abilify in other countries earlier. Flag as irrelevant New Government Report Affirms India's Patient-First Commitment on Pharma Patents The Wire It also reiterates that the Drug Controller General of India (DCGI), whose office receives applications for approving drugs, is not required, empowered or qualified to examine the existence of patents before approving drugs. The report says that any attempt by the DCGI to follow the idea of patent linkage ... Flag as irrelevant See more results | Edit this alert   You have received this email because you have subscribed to Google Alerts. Unsubscribe | View all your alerts Receive this alert as RSS feed Send Feedback